D.A. Davidson & Co. Verona Pharma PLC Transaction History

D.A. Davidson & Co.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$11.94 - $20.47 $10,746 - $18,423	900 Added 2.77%	33,400 $663,000
Q1 2023 Apr 25, 2023	SELL	$18.06 - $25.27 $27,089 - $37,905	-1,500 Reduced 4.41%	32,500 $652,000
Q4 2022 Feb 03, 2023	SELL	$9.84 - $26.13 $59,040 - $156,780	-6,000 Reduced 15.0%	34,000 $888,000
Q3 2022 Nov 07, 2022	SELL	$4.14 - $13.59 $18,630 - $61,155	-4,500 Reduced 10.11%	40,000 $409,000
Q2 2022 Jul 28, 2022	SELL	$3.55 - $5.06 $12,425 - $17,710	-3,500 Reduced 7.29%	44,500 $186,000
Q4 2021 Jan 31, 2022	BUY	$3.91 - $7.08 $31,280 - $56,640	8,000 Added 20.0%	48,000 $323,000
Q3 2021 Nov 15, 2021	SELL	$5.29 - $6.35 $10,051 - $12,065	-1,900 Reduced 4.53%	40,000 $219,000
Q1 2021 May 07, 2021	SELL	$7.08 - $9.33 $403,921 - $532,285	-57,051 Reduced 57.66%	41,900 $350,000
Q4 2020 Feb 10, 2021	BUY	$5.51 - $8.11 $63,728 - $93,800	11,566 Added 13.24%	98,951 $693,000
Q3 2020 Nov 02, 2020	SELL	$4.45 - $10.2 $130,941 - $300,135	-29,425 Reduced 25.19%	87,385 $545,000
Q2 2020 Aug 10, 2020	BUY	$3.6 - $6.12 $108,288 - $184,089	30,080 Added 34.68%	116,810 $547,000
Q1 2020 May 05, 2020	BUY	$2.16 - $7.28 $187,336 - $631,394	86,730 New	86,730 $357,000

167

68.7M

704K

685K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.75B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.